β-Like DNA polymerases and prospects for their use as targets in chemotherapy of tumors
Related Experiment Video
Updated: Jul 25, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
V V Davydov1, A A Bukhvostov1, D A Kuznetsov1
1Pirogov Russian National Research Medical University, Moscow, Russia.
Abstract:
DNA polymerases β are enzymes that perform repair of damaged DNA. In the cells of malignant tumors, there is a change in the production and properties of these enzymes, which is accompanied by altered viability of tumor cells. Analysis of the publications available in Russian and international databases (Pubmed, Elsevier) on the structure and properties of DNA polymerases β and their role in cell growth and proliferation, published over the past 20 years, has shown overexpression of genes encoding β-like DNA polymerases in many types of malignant tumors cells. This explains the maintenance of their viability and proliferative activity. Targeted inhibition of β-like DNA polymerases is accompanied by antiproliferative and antitumor effects. Stable paramagnetic isotopes of magnesium (25Mg2+) or other divalent metals (43Ca2+ and 67Zn2+) with uncompensated nuclear spin isotopes, as well as short single-stranded polydeoxyribonucleotides, can be used as promising antitumor pharmacophores.
Insights
DNA polymerases β are crucial for DNA repair. Their altered activity in tumors promotes cancer cell survival, but targeted inhibition shows antitumor effects, suggesting new therapeutic strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- DNA polymerases β (beta) are key enzymes in DNA repair.
- Dysregulation of DNA polymerases β is observed in malignant tumor cells, impacting cell viability and proliferation.
- Overexpression of β-like DNA polymerases supports tumor cell survival and proliferative activity.
Purpose of the Study:
- To analyze the role of DNA polymerases β in cancer cell growth and proliferation.
- To investigate the potential of targeting DNA polymerases β for cancer therapy.
Main Methods:
- Comprehensive literature review of publications on DNA polymerases β structure, properties, and function in cancer.
- Analysis of data from Russian and international databases (PubMed, Elsevier) over the past 20 years.
Main Results:
- Overexpression of genes encoding β-like DNA polymerases is a common feature in many malignant tumors.
- Targeted inhibition of β-like DNA polymerases demonstrates significant antiproliferative and antitumor effects.
- Stable paramagnetic isotopes (e.g., 25Mg2+) and polydeoxyribonucleotides show promise as antitumor pharmacophores.
Conclusions:
- Altered DNA polymerases β activity is linked to cancer cell viability and proliferation.
- Targeting DNA polymerases β represents a viable strategy for developing novel anticancer therapies.
- Specific isotopes and polynucleotides are potential candidates for antitumor drug development.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Tumor Immunotherapy
DNA Helicases